Hydroxyethyl Cellulose Hydrogel for Sustained Bacteriophage Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bacterial infections, particularly in vascular grafts, are inadequate due to antibiotic resistance and biofilm formation, leading to high morbidity, mortality, and increased hospitalization costs, with bacteriophages facing challenges in topical application and maintaining efficacy at the infection site.
Innovation Solution
A hydrogel composition comprising hydroxyethyl cellulose (HEC), bacteriophages, CaCl2, and glycerol, which is steam sterilizable and provides a stable gel scaffold for prolonged bacteriophage release at the infection site, suitable for surgical applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bacteriophages are applied topically to treat bacterial infections, then antibacterial efficacy is improved, but the ability to maintain bacteriophage activity at the application site deteriorates due to adhesive and flow dynamics
Solution Approach 1:
A hydrogel carrier system is introduced as an intermediary between the bacteriophage and the application site. The hydrogel comprises hydroxyethyl cellulose (HEC) as the base polymer, crosslinked with calcium chloride (CaCl2) to form a stable gel scaffold. This mediator enables controlled release of bacteriophages while maintaining their activity at the infection site for extended periods, overcoming the adhesive and flow dynamics issues of direct topical application.
Solution Approach 2:
The physical and chemical parameters of the delivery system are modified by incorporating glycerol into the hydrogel formulation. Glycerol adjusts the viscosity, swelling behavior, and degradation rate of the HEC gel, allowing optimization of bacteriophage release kinetics. This parameter adjustment ensures sustained bacteriophage activity while maintaining gel stability at the application site.
2Adaptability or versatility
If systemic antibiotic therapy is used to treat bacterial infections, then broad coverage is improved, but the ability to achieve effective saturation concentrations in inflammatory periprosthetic tissue deteriorates
Solution Approach 1:
The treatment approach shifts from systemic administration to localized application at the infection site. The hydrogel is applied directly to periprosthetic tissues, ensuring high concentrations of active antibacterial agents are delivered precisely where needed. This local delivery method overcomes the limitation of achieving effective saturation concentrations in inflammatory tissues through systemic circulation.
3Reliability
If bacteriophages are used to treat bacterial infections, then targeted antibacterial action is improved, but the complexity of regulatory approval and clinical study requirements increases
Solution Approach 1:
The hydrogel system is designed with multi-functionality to address both therapeutic and regulatory requirements. The HEC-based gel provides a well-characterized, biocompatible delivery platform with established safety profiles, while enabling the delivery of bacteriophages. This universal platform approach facilitates regulatory approval by combining a known safe carrier with the targeted antibacterial action of bacteriophages, simplifying the path to clinical approval.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel effectively treats and prevents bacterial infections by maintaining bacteriophage activity at the application site, reducing the risk of systemic adverse reactions, and providing a less invasive alternative to surgical resection.
Implementation Method 1
A hydrogel composition comprising hydroxyethyl cellulose (HEC), bacteriophages, CaCl2, and glycerol, which is steam sterilizable and provides a stable gel scaffold for prolonged bacteriophage release at the infection site
Implementation Method 2
which is steam sterilizable
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a hydrogel comprising hydroxyethyl cellulose (HEC) and bacteriophages.